Peer review reports
From: Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China
Original Submission | ||
---|---|---|
18 Jun 2023 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
13 Aug 2023 | Reviewed | Reviewer Report - Francisco Javier Parrondo García |
18 Aug 2023 | Reviewed | Reviewer Report |
12 Sep 2023 | Author responded | Author comments - Xun Zhuang |
Resubmission - Version 3 | ||
12 Sep 2023 | Submitted | Manuscript version 3 |
13 Sep 2023 | Author responded | Author comments - Xun Zhuang |
Resubmission - Version 4 | ||
13 Sep 2023 | Submitted | Manuscript version 4 |
14 Sep 2023 | Author responded | Author comments - Xun Zhuang |
Resubmission - Version 5 | ||
14 Sep 2023 | Submitted | Manuscript version 5 |
14 Sep 2023 | Author responded | Author comments - Xun Zhuang |
Resubmission - Version 6 | ||
14 Sep 2023 | Submitted | Manuscript version 6 |
16 Oct 2023 | Reviewed | Reviewer Report |
23 Oct 2023 | Reviewed | Reviewer Report - Francisco Javier Parrondo García |
Resubmission - Version 7 | ||
Submitted | Manuscript version 7 | |
Publishing | ||
23 Oct 2023 | Editorially accepted | |
13 Nov 2023 | Article published | 10.1186/s12889-023-17052-1 |